Screener
Zymeworks ZYME Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Zymeworks’s reported figures.
Based on trailing twelve months.
The source filing: Zymeworks’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001937653-26-000047
FAQ
- What is Zymeworks's return on equity?
- Zymeworks (ZYME) reported return on equity of -72.3% in Q2 2026.
- How has Zymeworks's return on equity changed year-over-year?
- Zymeworks's return on equity decreased by 263.5% year-over-year, from -19.9% to -72.3%.
- What is the long-term trend for Zymeworks's return on equity?
- Over 5 years (2020 to 2025), Zymeworks's return on equity has grown at a -13.5% compound annual growth rate (CAGR), from -55.1% to -26.7%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Zymeworks's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude